Activation of adrenoreceptors modulates synaptic transmission in the basolateral amygdala. Here, we investigated the effects of a 2 -adrenoreceptor activation on long-term depression and long-term potentiation in an in vitro slice preparation of the mouse basolateral amygdala. Field potentials and excitatory postsynaptic currents were evoked in the basolateral amygdala by stimulating the lateral amygdala. Norepinephrine (20 mM) reduced synaptic transmission and completely blocked the induction of long-term potentiation and long-term depression. The a 2 -adrenoreceptor antagonist yohimbine (2 mM) reversed this effect. The a 2 -adrenoreceptor agonist clonidine (10 mM) mimicked the effects of norepinephrine. The G i/o -protein inhibitor pertussis toxin (5 mg/mL) reversed the effect of clonidine. Long-term depression was blocked in the presence of o-conotoxin GVIA, but not o-agatoxin IVA. Clonidine inhibited voltageactivated Ca 2þ currents mediated via N-or P/Q-type Ca 2þ -channels. The inhibitory action of clonidine on long-term depression was reversed when inwardly rectifying K þ -channels were blocked by Ba 2þ (300 mM). The present data suggest that a 2 -adrenoreceptor activation impairs the induction of long-term depression in the basolateral amygdala by a G i/o -protein-mediated inhibition of presynaptic N-type Ca 2þ -channels and activation of inwardly-rectifying K þ -channels.
Introduction
The amygdala is an integral component of the limbic circuitry, and appears to be critically involved in the control of emotional and autonomic behaviour (Rogan & LeDoux, 1996; McKernan & Shinnick-Gallagher, 1997; Swanson & Petrovich, 1998) such as conditioned fear and anxiety (Davis et al., 1994; Maren & Fanselow, 1996; Pitkanen et al., 1997) . Extensive evidence indicates that stress hormones affect memory storage Salinas et al., 1997) and memory consolidation (Galvez et al., 1996) via noradrenergic mechanisms in the amygdala. The amygdala receives its noradrenergic input from the locus coeruleus (Fallon & Loughlin, 1987) . Consistent with the evidence for a high density of b-adrenoreceptor subtypes within the amygdala (Bylund & Snyder, 1976) , infusion of b-adrenergic receptor antagonists into the amygdala block norepinephrine (NE)-mediated effects on memory. The regional infusion of b-adrenergic receptor agonists into the basolateral amygdala (BLA) improves memory (Roozendaal et al., 1997) , probably by an increase in glutamatergic transmission. The amygdala also contains aadrenoreceptors (Zilles et al., 1993) . Activation of a-adrenoreceptors decreases glutamatergic transmission (Ferry et al., 1997) . The a 1 -adrenoreceptor subtype is located postsynaptically (Hardmann et al., 1996) . A recent report suggests that, in the BLA, a 1 -adrenoreceptors mediate their effects on memory storage only during concurrent badrenoreceptor activation (Ferry et al., 1999) . Presynaptically located a 2 -adrenoreceptors inhibit the release of neurotransmitter (Starke, 2001 ) and decrease amygdala kindling (Shouse et al., 1994) . In line with this antiepileptic effect, a 2 -adrenoreceptor activation decreases the firing rate of amygdala neurons in vivo (Freedman & Aghajanian, 1985) . The role of a 2 -adrenoreceptors in synaptic plasticity in the BLA has not yet been established. The present study is the first attempt to elucidate the involvement of a 2 -adrenoreceptor-coupled effector systems in the modulation of the induction of long-term potentiation (LTP) and long-term depression (LTD) in the BLA.
Materials and methods
Care and Use of the Government of Bavaria, Germany. All slices were placed in a storage chamber (22 8C) for at least 60 min and then transferred to the superfusion chamber (Luigs & Neumann, Ratingen, Germany) for recording. The flow rate of the aCSF through the chamber was 1.5 mL/min. The aCSF contained (in mM): NaCl, 125; KCl, 2.5; NaHCO 3 , 25; CaCl 2 , 2; MgCl 2 , 1; D-glucose, 25; NaH 2 PO 4 , 1.25; bubbled with a 95% O 2 /5% CO 2 mixture, and had a final pH of 7.4.
In the present study, we used a total of 45 mice and all experiments were performed on 163 slices. Usually one neuron was recorded from one slice. For each mouse, three-four slices were used.
Synaptic transmission and synaptic plasticity
Excitatory postsynaptic currents (EPSCs) and field potentials (FPs) were evoked by square pulse stimuli (0.066 Hz, 5-12 mA, 200 ms) delivered via bipolar tungsten electrodes insulated to the tip (5 mm tip diameter) and positioned in the lateral amygdaloid nucleus close to the external capsule (EC) (Fig. 1) . The FPs and EPSCs reflect the activity of a monosynaptic connection because their latency (2-3 ms) remained constant. FP recordings were made using glass microelectrodes (2-3 MO) filled with aCSF. The stimulus intensity was adjusted to produce a FP of approximately 50% of the maximum amplitude. High-frequency stimulation (HFS) trains of stimuli [5 trains at 100 Hz for 1 s, and 10 s interstimulus intervals (ISI)] to induce LTP were applied at the same stimulus intensity. For HFS and low-frequency stimulation (LFS; 1 Hz for 15 min) of FPs, the same stimulus intensities were used. Before HFS or LFS was applied, the responses to single stimuli had to remain stable for at least 20 min. Control LTP/LTD experiments were intercollated with pharmacological testing and results were only considered for analysis when control LTP slices showed at least a 20% change from baseline values 30 min after HFS. The voltage difference between the onset and the negative peak (a) and the difference between the negative peak and the succeeding positive peak (b) were measured. The amplitude of the FP was calculated as (a þ b)/2. All experiments were performed at room temperature (22-25 8C). The FPs were averaged before analysis. We stimulated every 15 s and averaged four consecutive FPs into one response, of which the amplitudes were then analysed, and which are shown as representative traces. Each dot in the graph represents the normalized amplitude of one averaged trace and is equal to 1 min.
Somata of principal neurons in the basolateral amygdala were identified by infrared-phase-contrast-enhanced videomicroscopy (Zeiss, Oberkochen, Germany; for details see Dodt et al., 2002) , and with these cells, whole-cell recordings were performed with glass pipettes (4-6 MO) containing (in mM): K-D-gluconate, 130; KCl, 5; EGTA, 0.5; Mg-ATP, 2; HEPES, 10; D-glucose, 5. Currents were recorded with a switched voltage-clamp amplifier (SEC 10 L, NPI electronic, Tamm, Germany) with switching frequencies of 60-80 kHz (25% duty cycle). Series resistance was monitored continuously and compensated in bridge mode (for details see Swandulla & Misgeld, 1990) . Neuronal input resistance was monitored by injecting a hyperpolarizing pulse (300 ms, À10 mV) periodically through the patch electrode (no current was injected during LTD induction). All patchclamp experiments were performed at room temperature (22-25 8C) at a holding potential of À70 mV. For LTD induction, LFS (1 Hz/ 900 pulses) was applied in bridge mode. Before LFS, the EPSC amplitudes to single stimuli had to remain stable for at least 15 min. Data are expressed as means AE standard error of the mean (SEM) of EPSC amplitude. The significance was tested (P < 0.05) using the Student's t-test at 30 min following termination of HFS or LFS. The recordings were amplified, filtered (3 kHz) and digitized (9 kHz) (ITC-16 Computer Interface, Instrutech, New York). The digitized responses were stored to disk on a Power Macintosh G3 computer with a data acquisition program (Pulse vs. 8.31; Heka electronic GmbH, Lambrecht, Germany).
Recording of Ca 2þ currents
The solution for preparation of slices contained (in mM): NaCl, 130; KCl, 3; NaHCO 3 , 26; CaCl 2 , 1; MgCl 2 , 5; NaH 2 PO 4 , 1.25; D-glucose, 10; bubbled with a 95% O 2 /5% CO 2 mixture to obtain a final pH of 7.38. Slices were maintained in a similar solution, but with CaCl 2 and MgCl 2 (both at 2 mM). For voltage-clamp recordings of Ba 2þ currents through N-and P/Q-type voltage-gated calcium channels (VGCCs), we used an external HEPES-based Ringer solution that contained (in mM): NaCl, 145; KCl, 3.5; HEPES, 10; BaCl 2 , 2; MgCl 2 , 2; D-glucose, 25; tetrodotoxin (TTX), 0.001; Ni 2þ , 0.05; nifedipine, 0.02 (pH 7.3 using NaOH); the internal solution contained (in mM): TEACl, 30; CsOH 3 O 3 S, 100; NaCl, 4; MgCl 2 , 1; CaCl 2 , 0.5; HEPES, 10; EGTA, 10; MgATP, 5; GTP-Tris, 0.3; creatine-PO 4 -Tris salt, 10 (pH 7.3 using TEAOH). Transmembrane currents were evoked by stepping the holding potential from À70 mV to 0 mV for 300 ms.
Recording of K þ currents
After whole-cell access was established, inwardly-rectifying K þ -channels (K ir -channels) currents were investigated in standard aCSF; patch electrodes (3.5-4.5 MO) were filled with (in mM): KCH 3 SO 3 , 120; CsCH 3 SO 3 , 120; CdCl 2 , 0.01; NaCl, 4; MgCl 2 , 0.5; CaCl 2 , 0.5; HEPES, 10; EGTA, 10; GTP-Tris, 0.3; Na 2 -creatine phosphate, 20 (pH 7.3 using NaOH). TTX (1 mM) has been added to block Na þ -channels. Cells were held at À70 mV and K ir currents were elicited by ramp voltage commands from À130 to 0 mV. To enhance K ir currents, controls and drug exposure were carried out in solutions with elevated extracellular K þ (30 mM) by substitution for Na þ . For investigating Ca 2þ currents, a standard P/4 protocol was used for the subtraction of leakage currents prior to analysis. (This protocol provides the option to generate leak pulses while averaging to eliminate slow capacitive currents arising from the jump from holding to leak holding).
Chemicals
Drugs were applied via the superfusion system. Compounds used: NE, clonidine, yohimbine, TEA (tetraethylammonium), Na 2 -creatine phosphate, SPcAMPs (sp-adenosine 3 0 ,5 0 -cyclic monophosphothionate), MDL12,330A (cis-N-(2-phenylcyclopentyl)-azacyclotridec-1-en-2amine monohydrochloride), forskolin (7b-acetoxy-6b-hydroxy-8,13-epoxy-labd-14-en-11-one) and nifedipine from RBI/Sigma, WAY100635 ((S)-N-tert-butyl-3-(4-(2-methoxyphenyl)-piperazin-1-yl)-2-phenylpropan-amide dihydrochloride) from Tocris. o-Conotoxin GVIA (o-CnTx) and o-agatoxin IVA (o-AgTx) were purchased from the Peptide Institute, Japan.
Results
The effect of a 2 -adrenoreceptor activation on basal synaptic transmission and synaptic plasticity Bath application of NE (20 mM) reduced evoked EPSCs to 48.9 AE 7.4% and increased the paired pulse facilitation (PPF; 50 ms pulse interval) ratio from 1.16 AE 0.14 to 1.51 AE 0.21 (both n ¼ 7, P < 0.05; Fig. 2A ). In addition, NE slightly depolarized BLA neurons (À62.2 AE 0.7 mV to À57.9 AE 0.7 mV) and reduced input resistance (267.4 AE 30.9 MO to 229.6 AE 30.2 MO). Previous studies from our laboratory demonstrated that a strong tetanic stimulation (5 Â 100 Hz for 1 s, and 10 s ISI) produced a robust potentiation of excitatory synaptic currents outlasting 60 min (Rammes et al., 2000) . In the present study, HFS potentiated synaptic responses to 135.9 AE 5.7% (Fig. 2B ). After application of NE (20 mM), HFS only induced short-term potentiation (STP), and the amplitude of synaptic responses returned to control levels after 20 min (Fig. 2B ). LTD was induced by LFS (1 Hz, 15 min; see Rammes et al., 2001) , which reduced the FP amplitude to 78.4 AE 6.0% (Fig. 2C ). NE (20 mM) completely blocked LTD (Fig. 2C ). The blocking effect of NE on LTP and LTD was significant (P < 0.001, both n ¼ 7). These effects on synaptic plasticity were mimicked by the a 2 -adrenoreceptor agonist clonidine (10 mM). Clonidine reduced EPSC amplitude to 76.6 AE 7.4% (n ¼ 7; P < 0.01), increased PPF ratio (control: 1.15 AE 0.05; in clonidine: 1.37 AE 0.08, P < 0.05; Fig. 3A ), hyperpolarized neurons from a resting potential of À62.2 AE 2.1 mV to À70.7 AE 2.4 mV (n ¼ 10, P < 0.01) and increased input resistance from 219.1 AE 28.5 MO to 270.9 AE 33.8 MO (n ¼ 10, P < 0.05). In the presence of clonidine, HFS resulted only in STP, and LFS failed to induce LTD ( Fig. 3B and C) .
To provide further evidence that the inhibition of synaptic plasticity in the BLA is mediated by a 2 -adrenoreceptor activation, we applied NE (20 mM) and the a 2 -adrenoreceptor antagonist yohimbine (2 mM) simultaneously. Because yohimbine also affects the serotonin type 1A (5-HT 1A ) receptor and mere activation of 5-HT 1A receptors blocks LTP (G. Rammes, unpublished results) and LTD (Rammes et al., 2001) , we additionally added the specific 5-HT 1A receptor antagonist WAY100635 (300 nM).Undertheseconditions,HFSofthe lateralnucleus of the amygdala (LA) resulted in LTP in the BLA, increasing the FP amplitudes to 133.6 AE 14.4% (n ¼ 8; P < 0.05; Fig. 4B ). LFS produced a robust LTD, reducing the amplitude of the synaptic responses to 78.3 AE 4.6% (Fig. 4C) . Importantly, the 5-HT 1A receptor antagonist WAY100635 alone had no effect on basal synaptic transmission or synaptic plasticity (Fig. 4A) . These experiments provide strong evidence that the activation of presynaptically located a 2 -adrenoreceptors might be responsible for the inhibition of LTP and LTD in the BLA. There is further evidence in favour of a presynaptic locus of expression for LTD in the mouse BLA from a previous study (Rammes et al., 2001) . In order to investigate the a 2 -adrenoreceptor-stimulated signal cascade responsible fortheinhibitionofsynapticplasticity,wenowfocusedontheinductionof LTD.
G i/o -proteins mediate a 2 -adrenoreceptor effects on LTD Adrenergic a 2 -receptors are coupled to inhibitory G-proteins (Saunders & Limbird, 1999) . To determine whether the inhibitory effect of a 2 -adrenoreceptor activation on the induction of LTD involves pertussis toxin-sensitive (PTX-sensitive) G-proteins, we incubated slices with PTX (5 mg/mL, 4-6 h at 37 8C). Treatment with PTX alone neither altered evoked FPs nor prevented LFS from inducing stable LTD (FPs were reduced to 81.0 AE 7.6%; Fig. 5A , left; n ¼ 8, P < 0.05). In slices pretreated with PTX, clonidine did not inhibit LTD (Fig. 5A, right) . In these experiments, LFS induced a pronounced LTD (FP reduction to 69.7 AE 8.7%; n ¼ 8, P < 0.05), indicating that blocking PTX-sensitive G-proteins reverses the inhibitory influence of clonidine on LTD. Thus, activation of G i/o -proteins seems to be a prerequisite for the a 2 -adrenoreceptor-mediated effect on LTD induction.
Inhibition of protein kinase A, but not of adenylate cyclase, is involved in the a 2 -adrenoreceptor-mediated effect of clonidine on LTD a 2 -Adrenoreceptors display various functions via G i/o -proteins. Their activation decreases adenylate cyclase (AC) activity (Saunders & Limbird, 1999) , thereby reducing protein kinase A (PKA) activity. First, we tested whether activation of AC affects the induction of LTD. After application of the specific AC inhibitor MDL 12,330A (Lippe & Ardizzone, 1991 ; 10 mM) for 40 min, LFS still induced robust LTD (MDL 12,330A itself slightly increased basal synaptic transmission to 108.7 AE 6.3%, data not shown). This finding indicates that activation of AC is not required to induce LTD (the FP amplitude was reduced to 78.4 AE 6.0% and 80.4 AE 6.1% for control and in MDL 12,330A, respectively; n ¼ 7 both P < 0.05; Fig. 5B ). Furthermore, if the inhibition of LTD by a 2 -adrenoreceptor activation was mediated by a decrease in AC activity, the effect of clonidine should be occluded by MDL 12,330A. However, in the presence of MDL 12,330A, clonidine still blocked the induction of LTD, and the FP amplitude returned to control levels (FP amplitude: 102.9 AE 2.6%; n ¼ 7; Fig. 5B , open circles). Consistent with a previous report (Wang et al., 1999) , application of the direct AC activator forskolin (25 mM) caused a LTPlike increase in FP amplitude (131.8 AE 6.9%, P < 0.05; data not shown) without occluding LTD. LFS reduced FP amplitudes to 76.9 AE 4% (n ¼ 7, P < 0.01; Fig. 5C , left) under these conditions. In the presence of forskolin, clonidine (10 mM) was still able to inhibit the induction of LTD. The FP amplitude returned to control levels after 30 min (FP amplitude: 100.2 AE 10.3%; n ¼ 7; Fig. 5C, right) . Together, these results demonstrate that the a 2 -adrenoreceptor-mediated effect on LTD does not depend on changes in AC activity.
In order to determine whether activation of PKA is crucial for LFSinduced LTD, we tested the influence of the PKA inhibitor H89 on LTD. When the slices were perfused with H89 (10 mM), the expression of LTD was significantly reduced (Fig. 6A) . Control LTD showed a decrease in FP amplitude to 75.4 AE 1.2%. In slices pretreated with H89, the FP amplitudes were decreased to 88.9 AE 5.9% (n ¼ 7, P < 0.05; right). These results indicate that PKA activation plays a role in LFSinduced LTD. Next, we investigated the role of cAMP and PKA in the a 2 -adrenoreceptor-mediated inhibitory effect of clonidine on LTD. We used the membrane-permeable cAMP analogue and PKA activator 3 . The a 2 -adrenoreceptor agonist clonidine (10 mM) mimics the inhibitory effect of NE on EPSC amplitude and synaptic plasticity. (A) Clonidine reduces EPSC amplitude to 76.6 AE 7.4% (n ¼ 7; P < 0.01) and increases PPF ratio (control: 1.15 AE 0.05; in clonidine: 1.37 AE 0.08). (B) In the presence of clonidine, HFS induces STP (after 30 min FP amplitude returned to 108.4 AE 9.3%; control is 144.9 AE 10.6%). (C) In the presence of clonidine, LFS fails to induce LTD (after 30 min FP amplitude returned to 100.7 AE 7.6%; control is 74.8 AE 3.9%). The effect of clonidine on LTP and LTD is significant (for LTP and LTD: P < 0.01, n ¼ 8). Insets show representative traces. . Adenylate cyclase is not involved in the a 2 -adrenoreceptor-mediated inhibitory effect on LTD. In the presence of MDL 12,330A (10 mM), clonidine blocks the induction of LTD (FP amplitude remains stable at 102.9 AE 2.6%, n ¼ 7; right, open circles). (C, left) The AC activator forskolin (25 mM) does not occlude LTD (LFS reduced FP amplitude to 76.9 AE 4%; n ¼ 7; left). In the presence of clonidine (10 mM), forskolin does not reverse the inhibition of LTD, and after 30 min FP amplitude returns to control levels (100.2 AE 10.3%; n ¼ 7; right). Insets show representative traces. SPcAMPs (25 mM). Superfusion with SPcAMPs for 40 min neither affected the expression of LTD (FP reduction to 86.3 AE 4.4%, n ¼ 8, P < 0.05; Fig. 6B, left) , nor FP amplitudes (data not shown). However, SPcAMPs reversed the effect of clonidine-induced a 2 -adrenoreceptor activation. Under these conditions, LFS permitted the induction of a pronounced LTD (FP amplitude was reduced to 77.4 AE 6.3%, n ¼ 8, P < 0.05; Fig. 6B, right) . These results are unexpected, as they suggest that the blocking effect of clonidine on LTD depends on a 2 -adrenoreceptor-regulated PKA activity, but is not mediated via the AC signal cascade.
Activation of a 2 -adrenoreceptors blocks LTD via modulation of K ir channels
Activation of the a 2 -adrenoreceptor can open K ir channels (Evans & Surprenant, 1993) . Clonidine increased the membrane current elicited by a hyperpolarization ramp in the BLA in a voltage-dependent manner, i.e. greater at more negative potentials (Fig. 6C, left) . At a membrane potential of À100 mV, clonidine increased the membrane current to 158.2 AE 18.2% (n ¼ 5, P < 0.05). Resting K ir current was subtracted from that additionally seen in the presence of clonidine (Fig. 6C, right) . In the presence of 300 mM Ba 2þ , clonidine failed to affect the membrane current (Fig. 6C, left) . Due to the elevated extracellular K þ concentration, the current activated has a reversal potential near À35 mV. To test whether the effect of clonidine on LTD is mediated by activating K ir -channels, we used Ba 2þ (300 mM), which blocks K ir -channels. In the neurons tested, clonidine hyperpolarized the membrane potential from À65.8 AE 2.7 mV to À73.7 AE 2.6 mV, an effect which was reversed by adding Ba 2þ ions to the superfusion medium (n ¼ 8), indicating the involvement of K ir -channels. Ba 2þ also reversed the clonidine-induced blockade of LTD, and LFS then reduced the EPSC amplitude to 52.1 AE 9.2% (n ¼ 7; Fig. 7A ). Ba 2þ did not reverse the clonidine-induced effect on EPSC amplitude, and Ba 2þ alone had no effect on LTD induction (data not shown).
Antagonizing N-type VGCCs suppresses LTD
There is evidence that activation of a 2 -adrenoreceptors inhibits presynaptic N-and P/Q-type VGCCs in caudal Raphé neurons (Li & Bayliss, 1998) . We tested whether the blockade of these channels with nonoverlapping concentrations of o-CnTx (1 mM; blocks N-type) and o-AgTx (200 nM; blocks P/Q-type) could affect the induction of LTD. Application of either o-CnTx or o-AgTx had no effect on input resistance or on membrane potential. o-CnTx or o-AgTx reduced the amplitude of EPSCs to 45.5 AE 8.6% and 87.6 AE 3.4%, respectively (n ¼ 5, P < 0.05; Fig. 7B, top) . After a selective blockade of P/Q-type Ca 2þ -channels by AgTx, LTD could still be induced (EPSC amplitude was depressed to 77.7 AE 7.8%, n ¼ 7, P < 0.05; Fig. 7B ). In contrast, antagonizing N-type Ca 2þ -channels by o-CnTx blocked the induction of LTD by LFS (Fig. 7B) . These results indicate that the induction of LTD requires a rise of Ca 2þ through N-type but not through P/Q-type Ca 2þ -channels.
Activation of a 2 -adrenoreceptors modulates VGCCs
It is still unknown whether a 2 -adrenoreceptor activation inhibits presynaptic N-or P/Q-type Ca 2þ -channels in the BLA. We examined the effects of NE and clonidine on VGCCs using Ba 2þ as the charge carrier. We applied Ni 2þ (50 mM) and nifedipine (20 mM) to block Tand L-type Ca 2þ -channels, respectively, as activation of T-and L-type Ca 2þ -channels does not play a role in modulation of LTD in the BLA (Rammes et al., 2000) . The Ca 2þ current, remaining after the T-and Ltype Ca 2þ -channels were blocked, was 46.8 AE 2.2% of the total Ca 2þ -current (Fig. 8B) . For the following analysis, this value was set to 100%.
Step depolarization of 300 ms duration from a holding potential of À70 mV evoked a whole-cell VGCC current which was reduced by NE (20 mM) or clonidine (10 mM) within 1-2 min after drug application to 52.3 AE 5.1% (n ¼ 8) and 44.3 AE 6.7% (n ¼ 8) of control (both P < 0.05), respectively (Fig. 8A) . To assess the contribution of Nand P/Q-type Ca 2þ -channels to the effect of clonidine, we used saturating, but nonoverlapping, concentrations of o-CnTx (1 mM) and o-AgTx (200 nM; Wheeler et al., 1994; Li & Bayliss, 1998; Sidach & Mintz, 2000) . Figure 8B shows the superimposed traces of evoked VGCC currents obtained in control, in the presence of Ni 2þ / nifedipine followed by either o-CnTx or o-AgTx in the absence or presence of clonidine. o-CnTx and o-AgTx reduced whole-cell currents to 50.1 AE 5.6% (n ¼ 8) and 40.2 AE 6.2% (n ¼ 9), respectively (Fig. 8C, left) . Applying o-CnTx and o-AgTx together reduced the current to 14.3 AE 2.9% (data not shown). Clonidine reduced the current in the presence of either o-CnTx or o-AgTx and produced a further reduction to 65.2 AE 6.2% (n ¼ 8, P < 0.05) and 48.7 AE 5.5% (n ¼ 9), respectively ( Fig. 8C, right ; residual current either in o-CnTx or oAgTx was set to 100%). When the N-type Ca 2þ current was blocked by o-CnTx, clonidine inhibited approximately 35% of the remaining current, and after blocking P/Q-type Ca 2þ current with o-AgTx, clonidine reduced approximately 51% of the residual current. These results indicate that a 2 -adrenoreceptor activation can reduce Ca 2þ entry through N-type and P/Q-type Ca 2þ -channels.
Discussion
The enhancement of learning and memory triggered by the release of stress hormones and NE after emotional arousal involves neuronal circuits in the BLA . The aim of the present study was to investigate the influence of NE on synaptic plasticity in this limbic structure. We used the combined application of extra-and intracellular recordings. There is no difference in the pharmacology of LTP/LTD in the BLA, when recording either FPs or EPSCs (Rammes et al., 2001 ; see also Huang & Kandel, 1998) . Interestingly, NE blocked both LTP and LTD in the BLA, suggesting that they share common mechanisms despite their functionally opposite effects on measured excitability. It remains to be shown whether intracellular Ca 2þ ions, which activate kinases as well as phosphatases (Lisman, 1994; Otani & Connor, 1998) and evoke bi-directional effects on calmodulin (DeMaria et al., 2001) , trigger these opposite effects. A recently suggested biophysical model of synaptic plasticity supports the notion of such a bi-directional effect (Castellani et al., 2001) .
The effects of NE on LTP and LTD were mimicked by the a 2 -adrenoreceptor agonist clonidine. Furthermore, the a 2 -adrenoreceptor antagonist yohimbine blocked the effects of NE on synaptic plasticity. Although clonidine is not a selective a 2 -adrenoreceptor agonist, these data speak in favour of an a 2 -adrenergic mechanism. a 1 -Adrenoreceptor-or imidazole receptor-dependent pathways, which might be additionally activated by clonidine, are obviously not involved in LTD suppression. Imidazole receptor activation even stimulates hippocampal LTD (Bolshakov & Siegelbaum, 1995; Normandin et al., 1996) , an effect which could be due to a phospholipase A2-dependent rise of intracellular arachidonic acid.
Presynaptic neurotransmitter release is controlled by N-and P/Qtype Ca 2þ -channels (Wheeler et al., 1994) . In the present study, both NE and clonidine inhibited N-and P/Q-type Ca 2þ -channels, however, with clonidine being slightly less effective on the amplitudes of EPSCs than NE. This may be explained by the fact that the opening of K irchannels by a 2 -adrenoreceptor activation alone triggers a robust hyperpolarization, which augments the driving force for Na þ ions and might counteract the N-and P/Q-type Ca 2þ -channel-mediated reduction of synaptic transmission under clonidine. NE activates a 1 -, a 2 -and b-adrenoreceptors. The fact that noradrenaline reduced EPSCs by 60% suggests a rather minor contribution of b-adrenoreceptors. Because a 1 -activation slightly reduces EPSP amplitude (Ferry et al., 1997) , it may explain why the simultaneous activation of a 1 -and a 2 -adrenoreceptors by NE reduces EPSC amplitude more effectively than the selective activation of a 2 -adrenoreceptors by clonidine. However, both noradrenaline and clonidine activate presynaptic a 2 -adrenoreceptors and thereby induce a similar increase of PPF.
LTD could be induced in the presence of clonidine, when a 2 -adrenoreceptor signal transduction was disrupted by PTX pretreatment. G i/o -proteins are coupled to the opening of K ir -channels as well as the blockade of voltage-gated Ca 2þ -channels (Clapham & Neer, 1997; Garcia et al., 1998) . Clonidine produces a robust hyperpolarization of BLA neurons. Previous studies have attributed this hyperpolarization to the opening of K ir -channels (Kavanaugh et al., 1991; Wickham et al., 1994) . In fact, clonidine opens K ir -channels in BLA neurons. Furthermore, in the presence of Ba 2þ , which blocks K irchannels, LTD could be induced while a 2 -adrenoreceptors are activated. These findings suggest that G i/o -protein-coupled K ir -channel opening is a possible mechanism by which a 2 -adrenoreceptor activation inhibits LTD.
In a previous study (Rammes et al., 2001) , we found that bathapplied BAPTA-AM, but not intracellularly applied BAPTA (1,2-bis(2-aminophenoxy)ethane-N,N,N 0 ,N 0 -tetraacetic acid), blocked LFS-induced LTD in the BLA. These results suggest that elevation of presynaptic, but not postsynaptic, calcium is a prerequisite for LTD induction, which is compatible with the view that LTD in the BLA is modulated primarily at presynaptic sites via a 2 -adrenoreceptor activation (Starke, 2001) . Such a mechanism enables a neuron to modulate the firing patterns of its afferents (Abbott et al., 1997) . In caudal Raphé neurons, activation of a 2 -adrenoreceptors causes a reduction of Ca 2þ currents (Li & Bayliss, 1998) , especially of Ca 2þ influx through N-and P/Q-type Ca 2þ -channels. Their role seems to be crucial for the induction of LTD, as presynaptic Ca 2þ influx links transmitter release to depolarization of the membrane (Cummings et al., 1996; Lee et al., 2000) , thereby modulating synaptic strength (DeMaria et al., 2001) . In the present study, we tested the importance of presynaptic N-and P/Qtype Ca 2þ -channels for the induction of LTD. Acute modulation of P/ Q-type Ca 2þ -channels may contribute to synaptic plasticity (Borst & Sakmann, 1998; Forsythe et al., 1998) by enriching the neural computational capabilities of the synapse (Abbott et al., 1997; Tsodyks & Markram, 1997) . In our study, antagonizing N-type Ca 2þ -channels suppressed LTD, whereas antagonizing P/Q-type Ca 2þ -channels had no effect. In previous studies, it has been shown that neither antagonizing L-type Ca 2þ -channels nor T-type Ca 2þ -channels affected LTD (Norris et al., 1998; Wang et al., 1999; Rammes et al., 2000) . The EPSC amplitude proved clearly less dependent on P/Q-type than Ntype Ca 2þ -channel activation, a finding which reflects a smaller fraction of P/Q-type Ca 2þ -channels on presynaptic terminals. The reduction of Ca 2þ currents by NE via a G i/o -protein link can thus be seen as another pathway by which a 2 -adrenoreceptors can inhibit LTD.
G i/o -proteins are also coupled to the inhibition of AC, which in turn regulates PKA activity. Unexpectedly, neither activation nor inactivation of AC affected the clonidine-induced suppression of LTD, whereas the activation of cAMP-dependent PKA reversed the inhibitory effect of clonidine on LTD. These findings suggest that the a 2 -adrenoreceptor-dependent suppression of LTD does not rely on AC but on PKA. Similar evidence for a cAMP-independent PKA signalling via activation of G-protein-coupled receptors has also been provided by investigating other signal transduction pathways. It has been found that corticotropin-releasing hormone, vasoactive peptides and the asubunit of G13 protein can interact with PKA in a cAMP-independent manner (Kuryshev et al., 1995; Dulin et al., 2001; Niu et al., 2001) . Concerning the a 2 -adrenoreceptor-dependent signalling, further investigations are necessary to elucidate these contradictory results.
Various reports stress the importance of PKA and a Ca 2þ -dependent equilibrium of kinase and phosphatase activity in memory consolidation and synaptic plasticity (Lisman, 1994; Abel et al., 1997; Bevilaqua et al., 1997) . In the present study, the activation of cAMPdependent PKA reversed the inhibitory effect of clonidine on LTD. Blocking PKA impeded the expression of LTD. It has been reported that PKA inhibits K þ -channels and activates Ca 2þ -channels by direct phosphorylation (Riedel et al., 1999) , counteracting G i/o -protein activity. Thus, a reduced PKA phosphorylation of K þ -channels and Ca 2þ -channels after a 2 -adrenoreceptor activation might block LTD. There is evidence that the phosphorylation of GABA A receptor subunits by PKA (Moss et al., 1995; Poisbeau et al., 1999) decreases GABAergic activity and, thus, could impair LTD induction (Rammes et al., 2001) . Furthermore, it has been shown that the G S -protein-coupled b-adrenoreceptor couples to G i/o -proteins following phosphorylation (Daaka et al., 1997) . Because the compound used in the present study to block PKA also inhibits cGMP-dependent protein kinase (cGK; Burkhardt et al., 2000) , it is still possible that induction of LTD depends at least partly also on cGK activation.
Both NE and clonidine reduced synaptic transmission and blocked synaptic plasticity in the BLA. Ba 2þ did not reverse the effect on synaptic transmission, but reversed the clonidine-induced inhibition of LTD. These results suggest that there is no direct correlation between a K ir -channel-induced reduction in amplitude and inhibition of synaptic plasticity. However, after antagonizing presynaptic N-type Ca 2þ -channels, there seems to be such a correlation, as blocking these channels reduces EPSC amplitude and inhibits LTD. These results are supported by previous data (Rammes et al., 2001) , showing that only buffering of presynaptic Ca 2þ with BAPTA-AM blocked LTD. On the other hand, antagonizing GABA A receptors, which led to an increase in EPSC, also inhibited LTD (Rammes et al., 2001 ). Thus, both mechanisms which cause a decrease and an increase in baseline synaptic transmission can impair the induction of LTD, indicating that this effect is not merely secondary to changes in basal synaptic strength.
In summary, our findings demonstrate that the induction of LTD in the BLA requires Ca 2þ influx through N-type Ca 2þ -channels, which are presumably located on the presynaptic site. Furthermore, the present data suggest that activation of a 2 -adrenoreceptors blocks LTD via G i/o -protein-mediated inhibition of N-type Ca 2þ -channels as well as activation of K ir s.
